These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 22030289

  • 21. Effect of pimobendan in addition to standard therapy for heart failure on prevention of readmission in elderly patients with severe chronic heart failure.
    Kawano H, Arakawa S, Satoh O, Matsumoto Y, Hayano M, Nakatomi D, Yamasa T, Maemura K.
    Geriatr Gerontol Int; 2014 Jan; 14(1):109-14. PubMed ID: 23581555
    [Abstract] [Full Text] [Related]

  • 22. Acute pharmacodynamic effects of pimobendan in client-owned cats with subclinical hypertrophic cardiomyopathy.
    Oldach MS, Ueda Y, Ontiveros ES, Fousse SL, Visser LC, Stern JA.
    BMC Vet Res; 2021 Feb 23; 17(1):89. PubMed ID: 33622315
    [Abstract] [Full Text] [Related]

  • 23. Use of pimobendan in feline congenital heart failure.
    Wainberg S.
    Can Vet J; 2013 Dec 23; 54(12):1164-6. PubMed ID: 24293678
    [Abstract] [Full Text] [Related]

  • 24. Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure.
    Hagemeijer F, Roth W, Brand HJ.
    J Cardiovasc Pharmacol; 1989 Dec 23; 14 Suppl 2():S57-64. PubMed ID: 2478794
    [Abstract] [Full Text] [Related]

  • 25. Acute and long-term hemodynamic effects of pimobendan (UD-CG 115 BS) in comparison with captopril.
    Hauf GF, Grom E, Jähnchen E, Roskamm H.
    J Cardiovasc Pharmacol; 1989 Dec 23; 14 Suppl 2():S49-56. PubMed ID: 2478793
    [Abstract] [Full Text] [Related]

  • 26. Longitudinal analysis of quality of life, clinical, radiographic, echocardiographic, and laboratory variables in dogs with myxomatous mitral valve disease receiving pimobendan or benazepril: the QUEST study.
    Häggström J, Boswood A, O'Grady M, Jöns O, Smith S, Swift S, Borgarelli M, Gavaghan B, Kresken JG, Patteson M, Åblad B, Bussadori CM, Glaus T, Kovačević A, Rapp M, Santilli RA, Tidholm A, Eriksson A, Belanger MC, Deinert M, Little CJ, Kvart C, French A, Rønn-Landbo M, Wess G, Eggertsdottir A, Lynne O'Sullivan M, Schneider M, Lombard CW, Dukes-McEwan J, Willis R, Louvet A, DiFruscia R.
    J Vet Intern Med; 2013 Dec 23; 27(6):1441-51. PubMed ID: 24010489
    [Abstract] [Full Text] [Related]

  • 27. Clinical efficacy and safety of pimobendan in treatment of heart failure--experience in Japan.
    Kato K.
    Cardiology; 1997 Dec 23; 88 Suppl 2():28-36. PubMed ID: 9142433
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.
    Boswood A, Gordon SG, Häggström J, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2018 Jan 23; 32(1):72-85. PubMed ID: 29214723
    [Abstract] [Full Text] [Related]

  • 32. Heart failure is common in diabetic cats: findings from a retrospective case-controlled study in first-opinion practice.
    Little CJ, Gettinby G.
    J Small Anim Pract; 2008 Jan 23; 49(1):17-25. PubMed ID: 18173774
    [Abstract] [Full Text] [Related]

  • 33. Clinical efficacy of pimobendan versus benazepril for the treatment of acquired atrioventricular valvular disease in dogs.
    Lombard CW, Jöns O, Bussadori CM.
    J Am Anim Hosp Assoc; 2006 Jan 23; 42(4):249-61. PubMed ID: 16822763
    [Abstract] [Full Text] [Related]

  • 34. Efficacy and safet of pimobendan in canine heart failure caused by myxomatous mitral valve disease.
    Smith PJ, French AT, Van Israël N, Smith SG, Swift ST, Lee AJ, Corcoran BM, Dukes-McEwan J.
    J Small Anim Pract; 2005 Mar 23; 46(3):121-30. PubMed ID: 15789807
    [Abstract] [Full Text] [Related]

  • 35. Effects of pimobendan on adverse cardiac events and physical activities in patients with mild to moderate chronic heart failure: the effects of pimobendan on chronic heart failure study (EPOCH study).
    Effects of Pimobendan on Chronic Heart Failure Study (EPOCH Study).
    Circ J; 2002 Feb 23; 66(2):149-57. PubMed ID: 11999639
    [Abstract] [Full Text] [Related]

  • 36. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G, Di Pasquale P, Parrinello G, Cardinale A, Scandurra A, Follone G, Argano C, Tuttolomondo A, Paterna S.
    Am Heart J; 2003 Mar 23; 145(3):459-66. PubMed ID: 12660669
    [Abstract] [Full Text] [Related]

  • 37. Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.
    Kubo SH, Gollub S, Bourge R, Rahko P, Cobb F, Jessup M, Brozena S, Brodsky M, Kirlin P, Shanes J.
    Circulation; 1992 Mar 23; 85(3):942-9. PubMed ID: 1537130
    [Abstract] [Full Text] [Related]

  • 38. Effects of long-term treatment with pimobendan on neurohumoral factors in patients with non-ischemic chronic moderate heart failure.
    Sasaki T, Kubo T, Komamura K, Nishikimi T.
    J Cardiol; 1999 Jun 23; 33(6):317-25. PubMed ID: 10396705
    [Abstract] [Full Text] [Related]

  • 39. [Reduction in left ventricular volume and improvement in hemodynamics following intravenous administration of pimobendan (UDGG 115 BS) in dilated cardiomyopathy].
    Permanetter B, Sebening H, Busch U, Lutilsky L.
    Z Kardiol; 1990 Aug 23; 79(8):565-72. PubMed ID: 2220013
    [Abstract] [Full Text] [Related]

  • 40. Hospital costs for treatment of acute heart failure: economic analysis of the REVIVE II study.
    de Lissovoy G, Fraeman K, Teerlink JR, Mullahy J, Salon J, Sterz R, Durtschi A, Padley RJ.
    Eur J Health Econ; 2010 Apr 23; 11(2):185-93. PubMed ID: 19582491
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.